Koyama Takashi, Munakata Masahito, Akima Takashi, Miyamoto Kazutaka, Kanki Hideaki, Ishikawa Shiro
Department of Cardiology, Saitama Municipal Hospital;
Department of Cardiology, Saitama Municipal Hospital.
J Vis Exp. 2019 May 28(147). doi: 10.3791/59672.
The beneficial effects of reperfusion therapy for ST-segment elevation myocardial infarction (STEMI) is attenuated by reperfusion injury. No approach has been proven successful in preventing this injury in the clinical setting to date. Meanwhile, a novel approach for cardioprotection in patients with STEMI, i.e., postconditioning with lactate-enriched blood (PCLeB), has recently been reported. PCLeB is a modification of the original protocol of postconditioning, aimed at increasing the delay in the recovery from tissue acidosis produced during ischemia. This was sought to achieve controlled reperfusion with tissue oxygenation and minimal lactate washout. In this modified postconditioning protocol, the duration of each brief reperfusion is gradually increased in a stepwise manner from 10 to 60 s. Each brief ischemic period lasts for 60 s. At the end of each brief reperfusion, injection of lactated Ringer's solution (20-30 mL) is performed directly into the culprit coronary artery immediately before the balloon inflation and the balloon is quickly inflated at the lesion site, so that the lactate is trapped inside the ischemic myocardium during each brief repetitive ischemic period. After seven cycles of balloon inflation and deflation, full reperfusion is performed. Stenting is performed thereafter, and the percutaneous coronary intervention is completed. Excellent in-hospital and 6 month outcomes in a limited number of patients with STEMI treated using PCLeB have already been reported. This method article provides a detailed description of each step of the PCLeB procedures.
再灌注治疗对ST段抬高型心肌梗死(STEMI)的有益作用会因再灌注损伤而减弱。迄今为止,在临床环境中尚无已被证实成功预防这种损伤的方法。与此同时,最近有报道称一种针对STEMI患者的新型心脏保护方法,即使用富含乳酸的血液进行后适应(PCLeB)。PCLeB是原始后适应方案的一种改良,旨在延长缺血期间产生的组织酸中毒恢复的延迟时间。这样做是为了实现组织氧合和最小化乳酸清除的可控再灌注。在这种改良的后适应方案中,每个短暂再灌注的持续时间从10秒逐步增加到60秒。每个短暂缺血期持续60秒。在每个短暂再灌注结束时,在球囊扩张前立即将乳酸林格氏液(20 - 30 mL)直接注入罪犯冠状动脉,并在病变部位迅速扩张球囊,以便在每个短暂重复缺血期将乳酸困在缺血心肌内。经过七次球囊扩张和放气循环后,进行完全再灌注。此后进行支架置入,完成经皮冠状动脉介入治疗。已经报道了有限数量使用PCLeB治疗的STEMI患者取得了出色的院内和6个月预后。本方法文章详细描述了PCLeB程序的每个步骤。